- Home
- HYFM vs HOTH Comparison
HYFM vs HOTH Comparison
Compare HYFM & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HYFM
- HOTH
- Stock Information
- Founded
- HYFM 1977
- HOTH 2017
- Country
- HYFM United States
- HOTH United States
- Employees
- HYFM N/A
- HOTH N/A
- Industry
- HYFM Industrial Machinery/Components
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- HYFM Industrials
- HOTH Health Care
- Exchange
- HYFM Nasdaq
- HOTH Nasdaq
- Market Cap
- HYFM 17.3M
- HOTH 15.6M
- IPO Year
- HYFM 2020
- HOTH 2019
- Fundamental
- Price
- HYFM $3.05
- HOTH $1.83
- Analyst Decision
- HYFM
- HOTH Strong Buy
- Analyst Count
- HYFM 0
- HOTH 3
- Target Price
- HYFM N/A
- HOTH $4.00
- AVG Volume (30 Days)
- HYFM 22.6K
- HOTH 2.0M
- Earning Date
- HYFM 11-06-2025
- HOTH 11-11-2025
- Dividend Yield
- HYFM N/A
- HOTH N/A
- EPS Growth
- HYFM N/A
- HOTH N/A
- EPS
- HYFM N/A
- HOTH N/A
- Revenue
- HYFM $161,102,000.00
- HOTH N/A
- Revenue This Year
- HYFM $5.45
- HOTH N/A
- Revenue Next Year
- HYFM $5.33
- HOTH N/A
- P/E Ratio
- HYFM N/A
- HOTH N/A
- Revenue Growth
- HYFM N/A
- HOTH N/A
- 52 Week Low
- HYFM $1.50
- HOTH $0.65
- 52 Week High
- HYFM $8.55
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- HYFM 29.93
- HOTH 79.54
- Support Level
- HYFM $2.65
- HOTH $1.53
- Resistance Level
- HYFM $3.30
- HOTH $1.87
- Average True Range (ATR)
- HYFM 0.32
- HOTH 0.13
- MACD
- HYFM -0.10
- HOTH 0.06
- Stochastic Oscillator
- HYFM 18.72
- HOTH 94.37
About HYFM Hydrofarm Holdings Group Inc.
Hydrofarm Holdings Group Inc is a distributor and manufacturer of agriculture equipment and supplies. Some of its products includes lighting solutions, growing media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies sold under proprietary, exclusive/preferred brands, or non-exclusive/distributed brands. The business is organized into two operating segments, the U.S. and Canada.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).